¼¼°èÀÇ ¿ø°Ý ³úÁ¹Áß ¼­ºñ½º ½ÃÀå
Telestroke Services
»óǰÄÚµå : 1739275
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 270 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,130,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,390,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¿ø°Ý ³úÁ¹Áß ¼­ºñ½º ¼¼°è ½ÃÀåÀº 2030³â±îÁö 48¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 19¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿ø°Ý ³úÁ¹Áß ¼­ºñ½º ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 48¾ï ´Þ·¯¿¡ ´ÞÇϰí, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 17.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÇãÇ÷¼º ³úÁ¹Áß ¼­ºñ½º´Â CAGR 16.3%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 26¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÃâÇ÷¼º ³úÁ¹Áß ¼­ºñ½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 18.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 4¾ï 8,820¸¸ ´Þ·¯, Áß±¹Àº CAGR 16.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿ø°Ý ³úÁ¹Áß ¼­ºñ½º ½ÃÀåÀº 2024³â¿¡ 4¾ï 8,820¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 7¾ï 3,790¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 16.1%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 15.6%¿Í 14.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 12.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¿ø°Ý ³úÁ¹Áß ¼­ºñ½º ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿ø°Ý ³úÁ¹Áß ¼­ºñ½º°¡ ³úÁ¹Áß ±Þ¼º±â °ü¸®¿Í ½Å°æÇÐÀû Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» º¯È­½ÃŰ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

¿ø°Ý ³úÁ¹Áß ¼­ºñ½º´Â Àϼ± ÀÓ»óÀÇ¿Í ½Å°æ°ú Àü¹®ÀÇÀÇ ½Ç½Ã°£ ½Ãû°¢ ÇùÁøÀ» ÅëÇØ ³úÁ¹Áß È¯ÀÚÀÇ ½Å¼ÓÇÑ ¿ø°Ý Æò°¡, Áø´Ü ¹× Ä¡·á °áÁ¤À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÇãÇ÷¼º ³úÁ¹Áß°ú °°Àº Ã̰¢À» ´ÙÅõ´Â ÁúȯÀº Áõ»ó ¹ß»ý ÈÄ ¸î ½Ã°£ ³» Ä¡·á°¡ ȯÀÚÀÇ ¿¹Èĸ¦ Á¿ìÇÕ´Ï´Ù. ¿ø°Ý ³úÁ¹ÁßÀº ƯÈ÷ 24½Ã°£ 365ÀÏ ½Å°æ°ú Àü¹®Àǰ¡ ¾ø´Â Áö¹æ º´¿øÀ̳ª ÀÚ¿øÀÌ ºÎÁ·ÇÑ º´¿ø¿¡¼­ Àü¹®ÀûÀÎ Ä¡·á¸¦ ½Å¼ÓÇÏ°Ô ¹ÞÀ» ¼ö ÀÖ°ÔÇÔÀ¸·Î½á »ý¸íÀ» ±¸ÇÏ´Â ¿ªÇÒÀ» ÇÕ´Ï´Ù.

ƯÈ÷, 24½Ã°£ 365ÀÏ ½Å°æ°ú°¡ ¾ø´Â Áö¹æ º´¿øÀ̳ª ÀÚ¿øÀÌ ºÎÁ·ÇÑ º´¿ø¿¡¼­´Â ´õ¿í ±×·¸½À´Ï´Ù. ÀÌ ¼­ºñ½º´Â ÀÀ±Þ½ÇÀ̳ª ÀÀ±Þ Ä¡·á ȯ°æ, ±×¸®°í À̵¿½Ä ³úÁ¹Áß À¯´ÖÀ» ÅëÇØ ½Å°æ°ú Àü¹®Àǰ¡ Á÷Á¢ Æò°¡ÇÏ¿© Ç÷Àü¿ëÇØÁ¦(tPA)ÀÇ Á¶±â Åõ¿©¿Í ±â°èÀû Ç÷ÀüÁ¦°Å¼úÀÇ ¼±º°À» µ½½À´Ï´Ù. ³úÁ¹ÁßÀº Àü ¼¼°èÀûÀ¸·Î Àå±âÀûÀÎ Àå¾Ö¿Í »ç¸ÁÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î, ¿ø°Ý ³úÁ¹ÁßÀº Áö¿¬À» ÃÖ¼ÒÈ­Çϰí, Ä¡·á ÇÁ·ÎÅäÄÝÀ» Ç¥ÁØÈ­Çϸç, ½Å°æ°ú Àü¹®ÀÇ¿¡ ´ëÇÑ Á¢±Ù¼ºÀÇ Áö¸®Àû °ÝÂ÷¸¦ ÇØ¼ÒÇÔÀ¸·Î½á ³úÁ¹Áß Ä¡·á ½Ã½ºÅÛ¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

±â¼ú Ç÷§Æû°ú ÅëÇÕµÈ ÀÓ»ó ¿öÅ©Ç÷ο찡 ¼­ºñ½º Á¦°øÀ» ¾î¶»°Ô °³¼±Çϰí Àִ°¡?

Telestroke Ç÷§ÆûÀº HIPAA ȣȯ È­»ó ȸÀÇ µµ±¸, ¿ø°Ý ¿µ»ó Áø´Ü ÅëÇÕ, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)ÀÇ »óÈ£ ¿î¿ë¼ºÀ» Ȱ¿ëÇÏ¿© ÀÓ»óÀÇ¿Í Àü¹®ÀÇ °£ÀÇ ¿øÈ°ÇÑ ÇùÁøÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. °íÈ­Áú ¿µ»ó Àü¼Û, ½Ç½Ã°£ CT ½ºÄµ °ËÅä, ÀÓ»óÀû ÆÇ´Ü Áö¿ø µµ±¸°¡ ³»ÀåµÇ¾î ÀÖ¾î ³úÁ¹Áß ÁßÁõµµ Á¡¼öÈ­, Áø´Ü, Ä¡·á ½ÂÀÎ µîÀ» È¿À²ÀûÀ¸·Î ¼öÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â´ÉµéÀº ±Þ¼º±â ³úÁ¹ÁßÀÇ ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÏ¿© µµ¾î Åõ ´Ïµé(Door to Needle) ¹× µµ¾î Åõ ÆãÅ©(Door to Puncture)ÀÇ ½Ã°£À» ´ÜÃà½Ãŵ´Ï´Ù.

¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ǰú Ŭ¶ó¿ìµå ±â¹Ý ´ë½Ãº¸µå¸¦ ÅëÇØ ½Å°æ°ú Àü¹®Àǰ¡ ¾îµð¼­³ª ¿ø°ÝÀ¸·Î Âü¿©ÇÒ ¼ö ÀÖÀ¸¸ç, ÀÚµ¿È­µÈ °æ°í¿Í ¾Ïȣȭ µÈ Åë½Å ÇÁ·ÎÅäÄÝÀ» ÅëÇØ Àû½Ã¿¡ Áø·á¸¦ ½ÃÀÛÇÏ°í ¾ÈÀüÇÑ µ¥ÀÌÅÍ ±³È¯À» º¸ÀåÇÕ´Ï´Ù. Áø´ÜÀ» ´õ¿í ºü¸£°Ô Çϰí ÀÎÀû ¿À·ù¸¦ ÁÙÀ̱â À§ÇÑ µµ±¸°¡ µµÀԵǰí ÀÖ½À´Ï´Ù. ³úÁ¹Áß °æ·ÎÀÇ µðÁöÅÐÈ­°¡ ÁøÇàµÊ¿¡ µû¶ó, ³úÁ¹Áß ¼­ºñ½º´Â Áø´Ü¿¡ ±×Ä¡Áö ¾Ê°í ±Þ¼º±â ÀÌÈÄ Ä¡·á °èȹ ¹× °á°ú ÃßÀûÀ» Æ÷ÇÔÇÑ Á¾ÇÕÀûÀÎ Ä¡·á Á¶Á¤ Ç÷§ÆûÀ¸·Î ÁøÈ­Çϰí ÀÖ½À´Ï´Ù.

¿ø°Ý ³úÁ¹Áß ¼­ºñ½º ¼ö¿ä¸¦ ÁÖµµÇÏ´Â ÀÇ·á ½Ã¼³ ¹× Áö¿ª ÀÇ·á ½Ã½ºÅÛÀº?

¿ø°Ý ³úÁ¹Áß¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇÏ´Â °÷Àº Áö¹æ º´¿ø, ÁßÁõ Á¢±Ù ½Ã¼³, ¼Ò±Ô¸ð Áö¿ª ÀÀ±Þ½Ç µîÀÔ´Ï´Ù. ÀÌµé º´¿øµéÀº ½Å¼ÓÇÑ ³úÁ¹Áß Ä¡·á¸¦ À§ÇØ ¿ø°Ý ³úÁ¹Áß ¼­ºñ½º¸¦ ÀÌ¿ëÇϰí ÀÖÀ¸¸ç, ³ôÀº ¼öÁØÀÇ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϰí, Áï°¢ÀûÀÎ À̼ÛÀÌ ÇÊ¿äÇÑ È¯ÀÚ¸¦ È®º¸Çϱâ À§ÇØ ¿ø°Ý ³úÁ¹Áß ¼­ºñ½º¸¦ ÀÌ¿ëÇϰí ÀÖ½À´Ï´Ù. 3Â÷ ÀÇ·á¼¾ÅÍ¿Í ´ëÇк´¿øµéµµ ³úÁ¹Áß Àü¹®Áö½ÄÀ» Áö¿ª º´¿ø ³×Æ®¿öÅ©¿¡ È®ÀåÇÏ°í ½Ã½ºÅÛ ÀüüÀÇ ³úÁ¹Áß ´ëÀÀ ´É·ÂÀ» Çâ»ó½Ã۱â À§ÇØ ³úÁ¹Áß Çãºê¸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù.

Áö¸®ÀûÀ¸·Î´Â ºÏ¹Ì°¡ ³úÁ¹Áß ³×Æ®¿öÅ©ÀÇ È®¸³, Áø·á º¸»óÀÇ ÇüÆò¼º, ³úÁ¹Áß Ä¡·á ÁöÇ¥¿Í °ü·ÃµÈ º´¿ø ÀÎÁõ ¿ä°Ç µîÀÇ ÀÌÀ¯·Î µµÀÔÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä«¿¡¼­´Â ³úÁ¹Áß ºÎ´ã°ú Àü¹®ÀÇ ºÎÁ·¿¡ ´ëÀÀÇϱâ À§ÇØ ¹Î°ü ÇÕµ¿À¸·Î ½Ã¹üÀûÀ¸·Î ½ÃÇàµÇ°í ÀÖ½À´Ï´Ù. °¢±¹ Á¤ºÎ°¡ ³úÁ¹Áß Á¶±â Ä¡·áÀÇ °æÁ¦Àû, ÀÓ»óÀû ÀÌÁ¡À» ÀνÄÇÔ¿¡ µû¶ó ¼±Áø±¹°ú ½ÅÈï±¹ ½ÃÀå¿¡¼­ ¿ø°Ý ³úÁ¹Áß ÀÎÇÁ¶ó¿¡ ´ëÇÑ Áö¿øÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

º¸Çè »óȯ ¸ðµ¨, ǰÁú ±âÁØ, ÀÓ»ó °á°ú°¡ ½ÃÀå ¼º¼÷µµ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

¸¹Àº Áö¿ª¿¡¼­ ¸ÞµðÄɾî, ¸ÞµðÄÉÀ̵å, ¹Î°£ º¸Çè»çÀÇ ¿ø°Ý ³úÁ¹Áß Áø·á¿¡ ´ëÇÑ µ¿µîÇÑ »óȯÀÌ µµÀÔÀÇ Áß¿äÇÑ °è±â°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Joint Commission ¹× American Heart Association°ú °°Àº ±â°ü¿¡¼­ ³úÁ¹Áß ¼¾Å͸¦ ÀÎÁõÇÒ ¶§ 24½Ã°£ 365ÀÏ ½Å°æ°úÀû Ä¿¹ö¸®Áö¸¦ Áõ¸íÇØ¾ß ÇÏ´Â °æ¿ì°¡ ¸¹Àºµ¥, ¿ø°Ý ³úÁ¹Áß´Â ÀÌ¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç°Áú º¸Áõ ÇÁ·¹ÀÓ¿öÅ©´Â ¿ø°Ý ³úÁ¹ÁßÀ» ÀÎÁõµÈ ³úÁ¹Áß ÇÁ·Î±×·¥ÀÇ Ç¥ÁØ ±¸¼º¿ä¼Ò·Î °ø½ÄÈ­Çϰí ÀÖ½À´Ï´Ù.

¿ø°Ý ³úÁ¹Áß ¼­ºñ½º°¡ Ä¡·á ½ÃÀÛÀ» ¾Õ´ç±â°í, tPA Åõ¿©À²À» ³ôÀ̸ç, ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÑ´Ù´Â °ÍÀº Àӻ󿬱¸¸¦ ÅëÇØ Áö¼ÓÀûÀ¸·Î ÀÔÁõµÇ°í ÀÖ½À´Ï´Ù. ÇÁ·Î±×·¥ÀÇ È¿°ú¸¦ Æò°¡Çϱâ À§ÇØ ¼öÁ¤µÈ Rankin Á¡¼ö, Àç¿øÀϼö, 90ÀÏ ±â´É ȸº¹ µîÀÇ ÁöÇ¥°¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. °¡Ä¡ ±â¹Ý Ä¡·á ¸ðµ¨ÀÌ Á¤ÂøµÊ¿¡ µû¶ó ¿ø°Ý ³úÁ¹ÁßÀº ÀÓ»ó °á°ú °³¼±»Ó¸¸ ¾Æ´Ï¶ó ºÒÇÊ¿äÇÑ Àü¿øÀ» ÁÙÀ̰í, Ä¡·á ÀÌ¿ëÀ» ÃÖÀûÈ­Çϸç, ½ÇÀû¿¡ ±â¹ÝÇÑ »óȯ ±âÁØÀ» ´Þ¼ºÇÏ´Â µî ±× À¯¿ë¼ºÀÌ ÀÔÁõµÇ°í ÀÖ½À´Ï´Ù.

¿ø°Ý ³úÁ¹Áß ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀå µ¿·ÂÀº ¹«¾ùÀϱî?

¿ø°Ý ³úÁ¹Áß ¼­ºñ½º ½ÃÀåÀº ³úÁ¹Áß Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» °³¼±Çϰí, Ä¡·á Áö¿¬À» ÁÙÀ̰í, ¼¼ºÐÈ­µÈ ÀÇ·á Áö¿ª¿¡ Àü¹®ÀǸ¦ È®´ëÇϰíÀÚ ÇÏ´Â Àü ¼¼°èÀûÀÎ ¿ä±¸¿¡ µû¶ó ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ °Ç°­ÀÇ ¼º¼÷µµ, À¯¸®ÇÑ º¸Çè »óȯ, ÀÓ»óÀû À¯¿ë¼º¿¡ ´ëÇÑ Áõ°ÅÀÇ ÃàÀû°ú ÇÔ²² ¿ø°Ý ³úÁ¹ÁßÀº °øÁ¤Çϰí Àû½Ã¿¡ ³úÁ¹Áß Ä¡·á¸¦ ½ÇÇöÇÏ´Â Áß¿äÇÑ ¼ö´ÜÀÌ µÇ°í ÀÖ½À´Ï´Ù. º´¿ø°ú ÀÇ·á ½Ã½ºÅÛÀº ¿ø°Ý ³úÁ¹ÁßÀ» Ä¡·áÀÇ Áú Çâ»óÀ» À§ÇÑ Çʼö »çÇ×ÀÌÀÚ ³×Æ®¿öũȭµÈ ÀÇ·á Á¦°øÀ» À§ÇÑ Àü·«Àû ¼ö´ÜÀ¸·Î ÀνÄÇϰí ÀÖ½À´Ï´Ù.

¾ÕÀ¸·ÎÀÇ ¼ºÀåÀº ÀÌÇØ°ü°èÀÚµéÀÌ ¾î¶»°Ô È¿°úÀûÀ¸·Î Ç÷§Æû ÅëÇÕÀ» È®ÀåÇϰí, ½Å°æ°ú Àü¹®ÀÇÀÇ ¿ª·®À» ÃæÁ·½Ã۸ç, ³úÁ¹Áß °æ·Î¸¦ ÃÖÀûÈ­ÇÏ°í ¿ø°Ý ³úÁ¹Áß ¿öÅ©Ç÷ο츦 Á¶Á¤ÇÏ´ÂÁö¿¡ µû¶ó Á¿ìµÉ °ÍÀÔ´Ï´Ù. ¿ø°Ý ³úÁ¹Áß ¼­ºñ½º°¡ ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ Àå±âÀûÀÎ ÀÓ»óÀû °¡Ä¡¿Í ¾÷¹« È¿À²¼ºÀ» À¯ÁöÇÒ ¼ö ÀÖ´ÂÁö ¿©ºÎ°¡ ±Þ¼º ³úÇ÷°ü Áúȯ¿¡ ´ëÇÑ ¼¼°è ´ëÀÀÀ» À籸¼ºÇÏ´Â µ¥ ÀÖ¾î ¿ø°Ý ³úÁ¹Áß ¼­ºñ½º°¡ ¾î¶² ¿ªÇÒÀ» ÇÒ ¼ö ÀÖ´ÂÁö¸¦ °áÁ¤ÇÕ´Ï´Ù.

ºÎ¹®

³úÁ¹Áß À¯Çü(ÇãÇ÷¼º ³úÁ¹Áß, ÃâÇ÷¼º ³úÁ¹Áß, Àϰú¼º ³úÇãÇ÷¹ßÀÛ), Ç÷§Æû Àü°³(Ŭ¶ó¿ìµå, ¿ÂÇÁ·¹¹Ì½º), ¿ëµµ(»ó´ã, Ä¡·á, ±¸±Þ ¼­ºñ½º, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø, Àü¹® Ŭ¸®´Ð, ÀçÅà ÇコÄɾî, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 36°³»ç)

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ÀÎÀ§ÀûÀÎ ¸ÅÃâ¿ø°¡ Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Global Industry Analysts´Â ¼¼°è ÁÖ¿ä ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®(1,4,949¸í), ½ÌÅ©ÅÊÅ©(62°³ ±â°ü), ¹«¿ª ¹× »ê¾÷ ´Üü(171°³ ±â°ü)ÀÇ Àü¹®°¡µéÀÇ ÀǰßÀ» ¸é¹ÐÈ÷ °ËÅäÇÏ¿© »ýŰ迡 ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ°í »õ·Î¿î ½ÃÀå Çö½Ç¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¸ðµç ÁÖ¿ä ±¹°¡ÀÇ Àü¹®°¡¿Í °æÁ¦ÇÐÀÚµéÀÌ °ü¼¼¿Í ±×°ÍÀÌ ÀÚ±¹¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀǰßÀ» ÃßÀû Á¶»çÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀÌ·¯ÇÑ È¥¶õÀÌ ÇâÈÄ 2-3°³¿ù ³»¿¡ ¸¶¹«¸®µÇ°í »õ·Î¿î ¼¼°è Áú¼­°¡ º¸´Ù ¸íÈ®ÇÏ°Ô È®¸³µÉ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, Global Industry Analysts´Â ÀÌ·¯ÇÑ »óȲÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇϰí ÀÖ½À´Ï´Ù.

2025³â 4¿ù : Çù»ó ´Ü°è

À̹ø 4¿ù º¸°í¼­¿¡¼­´Â °ü¼¼°¡ ¼¼°è ½ÃÀå Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú Áö¿ªº° ½ÃÀå Á¶Á¤¿¡ ´ëÇØ ¼Ò°³ÇÕ´Ï´Ù. ´ç»çÀÇ ¿¹ÃøÀº °ú°Å µ¥ÀÌÅÍ¿Í ÁøÈ­ÇÏ´Â ½ÃÀå ¿µÇâ¿äÀÎÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.

2025³â 7¿ù : ÃÖÁ¾ °ü¼¼ Àç¼³Á¤

°í°´´Ôµé²²´Â °¢ ±¹°¡º° ÃÖÁ¾ ¸®¼ÂÀÌ ¹ßÇ¥µÈ ÈÄ 7¿ù¿¡ ¹«·á ¾÷µ¥ÀÌÆ® ¹öÀüÀ» Á¦°øÇØ µå¸³´Ï´Ù. ÃÖÁ¾ ¾÷µ¥ÀÌÆ® ¹öÀü¿¡´Â ¸íÈ®ÇÏ°Ô Á¤ÀÇµÈ °ü¼¼ ¿µÇ⠺м®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

»óÈ£ ¹× ¾çÀÚ °£ ¹«¿ª°ú °ü¼¼ÀÇ ¿µÇ⠺м®:

¹Ì±¹ <> Áß±¹ <> ¸ß½ÃÄÚ <> ij³ª´Ù <> EU <> ÀϺ» <> Àεµ <> ±âŸ 176°³±¹

¾÷°è ÃÖ°íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ® : Global Industry AnalystsÀÇ Áö½Ä ±â¹ÝÀº ±¹°¡, ½ÌÅ©ÅÊÅ©, ¹«¿ª ¹× »ê¾÷ ´Üü, ´ë±â¾÷, ±×¸®°í ¼¼°è °è·® °æÁ¦ »óȲÀÇ Àü·Ê ¾ø´Â ÆÐ·¯´ÙÀÓ ÀüȯÀÇ ¿µÇâÀ» °øÀ¯ÇÏ´Â ºÐ¾ßº° Àü¹®°¡ µî °¡Àå ¿µÇâ·Â ÀÖ´Â ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ Æ÷ÇÔÇÑ 14,949¸íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ ÃßÀûÇϰí ÀÖ½À´Ï´Ù. 16,491°³ ÀÌ»óÀÇ º¸°í¼­ ´ëºÎºÐ¿¡ ¸¶ÀϽºÅæ¿¡ ±â¹ÝÇÑ 2´Ü°è Ãâ½Ã ÀÏÁ¤ÀÌ Àû¿ëµÇ¾î ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Telestroke Services Market to Reach US$4.8 Billion by 2030

The global market for Telestroke Services estimated at US$1.9 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 17.0% over the analysis period 2024-2030. Ischemic Stroke Services, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Hemorrhagic Stroke Services segment is estimated at 18.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$488.2 Million While China is Forecast to Grow at 16.1% CAGR

The Telestroke Services market in the U.S. is estimated at US$488.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$737.9 Million by the year 2030 trailing a CAGR of 16.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.6% and 14.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

Global Telestroke Services Market - Key Trends & Drivers Summarized

Why Are Telestroke Services Transforming Acute Stroke Management and Access to Neurological Care?

Telestroke services enable rapid remote assessment, diagnosis, and treatment decision-making for stroke patients through real-time audio-visual consultations between frontline clinicians and neurologists. In time-critical conditions like ischemic stroke, where outcomes are heavily dependent on intervention within the first few hours of symptom onset, telestroke plays a life-saving role by expediting access to specialized care-especially in rural and resource-limited hospitals without 24/7 neurology coverage.

These services support early administration of thrombolytics (tPA) and triage for mechanical thrombectomy by providing neurologist-guided evaluations directly into emergency rooms, urgent care settings, or even via mobile stroke units. As stroke remains a leading cause of long-term disability and death globally, telestroke is becoming integral to stroke systems of care by minimizing delays, standardizing treatment protocols, and bridging geographic disparities in access to neurological expertise.

How Are Technological Platforms and Integrated Clinical Workflows Enhancing Service Delivery?

Telestroke platforms leverage HIPAA-compliant video conferencing tools, teleradiology integration, and electronic health record (EHR) interoperability to enable seamless clinician-to-specialist coordination. High-definition imaging transmission, real-time CT scan reviews, and embedded clinical decision support tools allow for efficient stroke severity scoring, diagnosis, and treatment authorization. These capabilities are streamlining acute stroke workflows and supporting faster door-to-needle and door-to-puncture times.

Mobile applications and cloud-based dashboards are enabling neurologists to participate remotely from any location, while automated alerts and encrypted communication protocols ensure timely consultation initiation and secure data exchange. AI-enhanced triage and imaging tools are being incorporated to further accelerate diagnosis and reduce human error. As stroke pathways become more digitized, telestroke services are evolving into comprehensive care coordination platforms that extend beyond diagnosis to include post-acute care planning and outcome tracking.

Which Healthcare Settings and Regional Health Systems Are Driving Demand for Telestroke Services?

Demand for telestroke is being driven by rural hospitals, critical access facilities, and smaller community emergency departments that often lack on-site neurologists. These institutions use telestroke services to enable rapid stroke consults, meet quality benchmarks, and retain patients who would otherwise require immediate transfer. Tertiary and academic medical centers are also deploying telestroke hubs to extend their stroke expertise across regional hospital networks, improving system-wide stroke response capabilities.

Geographically, North America leads adoption due to established stroke networks, reimbursement parity, and hospital accreditation requirements tied to stroke care metrics. Europe and Australia are scaling regional telestroke programs within national healthcare systems, while parts of Asia-Pacific and Latin America are piloting public-private initiatives to address stroke burden and specialist shortages. As governments recognize the economic and clinical benefits of early stroke intervention, support for telestroke infrastructure is expanding across both developed and emerging markets.

How Are Reimbursement Models, Quality Standards, and Clinical Outcomes Influencing Market Maturity?

Reimbursement parity for telehealth stroke consults-enabled by Medicare, Medicaid, and private insurers in many regions-has been a key catalyst for adoption. Additionally, stroke center certifications from organizations such as The Joint Commission and American Heart Association often require evidence of 24/7 neurological coverage, for which telestroke offers a compliant and cost-effective solution. These quality assurance frameworks are formalizing telestroke as a standard component of accredited stroke programs.

Clinical studies continue to demonstrate that telestroke services lead to faster treatment initiation, higher tPA administration rates, and improved patient outcomes. Metrics such as modified Rankin scores, hospital length of stay, and 90-day functional recovery are increasingly used to evaluate program effectiveness. As value-based care models take root, telestroke is proving its utility not only in improving clinical results but also in reducing unnecessary transfers, optimizing care utilization, and meeting performance-based reimbursement criteria.

What Are the Factors Driving Growth in the Telestroke Services Market?

The telestroke services market is growing rapidly, driven by the global need to improve stroke care access, reduce treatment delays, and expand specialist reach across fragmented healthcare geographies. Digital health maturity, favorable reimbursement, and mounting evidence of clinical benefit are reinforcing telestroke as a critical enabler of equitable and timely stroke intervention. Hospitals and health systems are increasingly viewing telestroke as both a quality-of-care imperative and a strategic tool for networked care delivery.

Looking forward, growth will be influenced by how effectively stakeholders can scale platform integration, address neurologist capacity, and align telestroke workflows with stroke pathway optimization. Whether telestroke services can sustain long-term clinical value and operational efficiency across diverse care settings will determine their role in reshaping the global response to acute cerebrovascular events.

SCOPE OF STUDY:

The report analyzes the Telestroke Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Stroke Type (Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attack); Platform Deployment (Cloud, On-Premise); Application (Counseling, Treatment, Emergency Service, Other Applications); End-Use (Hospitals, Specialty Clinics, Home Healthcare Settings, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â